A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 21, 2021

Primary Completion Date

June 27, 2023

Study Completion Date

June 27, 2023

Conditions
Anemia Postoperative
Interventions
DRUG

Ferric Derisomaltose

Single-dose intravenous infusion, 20 mg/kg body weight, postoperative day 1

DRUG

Ferrous sulfate

Oral therapy, 100 mg twice daily, from postoperative day 4 until 4-week follow-up

DRUG

normal saline

Single-dose infusion (placebo), postoperative day 1

Trial Locations (1)

8200

Aarhus University Hospital, Aarhus

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

University of Aarhus

OTHER

collaborator

Pharmacosmos A/S

INDUSTRY

lead

Michael Kremke

OTHER